Latest Legal Fees News

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.

RocketBoots Limited has secured new trial contracts worth $208,000 with major retail banks in Australia and Mexico, while expanding its international sales pipeline and appointing a seasoned CFO/COO to support growth.

Northern Minerals Limited reported a net operating cash outflow of AUD 6.61 million for Q3 2025, ending the quarter with AUD 17.48 million in cash and equivalents and a solid financing facility.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

Bod Science Limited reported a $576,000 net operating cash outflow for the September quarter, sustained by funding from Biortica Agrimed Limited under a Deed of Company Arrangement as it pursues a backdoor listing.

Energy Action Limited reported a robust FY25 with a 12% revenue increase and a 247% jump in statutory profit, underpinned by disciplined expense management and contract growth.

The company posted a 25% increase in net loss to $709,247 for the year ended June 2025, alongside a sharp 55% drop in revenue. Key factors include significant trading losses and lower interest income, with no dividends declared.

WAM Active Limited reported a robust FY2025 with a 26.4% investment portfolio gain and a steady fully franked dividend of 6.0 cents per share, underscoring its active management approach amid evolving market conditions.

Nuix Limited reported a slight revenue increase to $221.5 million for FY25 but swung to a net loss of $9.2 million, weighed down by rising legal fees and restructuring costs. The company’s AI-driven Nuix Neo platform showed strong contract growth, while cash EBITDA improved significantly.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

IGNITE Limited reports a notable turnaround with statutory profit doubling despite a 7% revenue decline, alongside a reinstated dividend reinvestment plan and a fully franked dividend.

ASX has revealed it expects to incur an additional $25 million to $35 million in operating expenses in FY26 due to the ongoing ASIC compliance inquiry. Despite this, the company remains committed to its five-year strategy focused on technology and risk management.